Fig. 8From: Hepatitis B virus P protein initiates glycolytic bypass in HBV-related hepatocellular carcinoma via a FOXO3/miRNA-30b-5p/MINPP1 axisThe clinical value of MINPP1 was tested by bioinformatic analysis. a The association of MINPP1 with HBV-positive HCC clinical and pathological stages was verified in a HCC cohort from the TCGA database. b A Forest plot was plotted to present the results of Cox regression analysis conducted to show the clinical information and MINPP1 for survival in the TCGA database. c KM analysis of the survival of high and low MINPP1expression groups. d Schematic illustration of the HBp/FOXO3/miRNA-30b-5p/MINPP1 axis that promotes HBV-positive HCC development through the glycolytic bypass. **P < 0.01, ***P < 0.001, ****P < 0.0001, NS: No statisticsBack to article page